SavedAdd your journal

Journals / MN Oftalmoloji / 2019 / Cilt: 26 - Sayı: 2

Macular Hole Development Following Intravitreal Injection in a Patient with Exudative Age-Related Macular Degeneration

Eksüdatif Yaşa Bağlı Maküla Dejenerasyonlu Hastada İntravitreal Enjeksiyon Sonrası Maküla Deliği Gelişimi

Gülşah GÜMÜŞ
Gökhan DEMİR
Zeynep ALKIN
Pages
110–113
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, we aimed to present a case who had persistent vitreomacular traction induced macular hole following intravitreal ranibizumab injection due to exudative age-related macular degeneration and underwent pars plana vitrectomy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Macular hole formation after intravitreal injection is one of the rare complications.
📊
Key Findings & Data:There may be various mechanisms that may be responsible for macular hole formation.
💡
Conclusion & Impact:In this study, we aimed to present a case who had persistent vitreomacular traction induced macular hole following intravitreal ranibizumab injection due to exudative age-related macular degeneration and underwent pars plana vitrectomy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Macular hole formation after intravitreal injection is one of the rare complications. There may be various mechanisms that may be responsible for macular hole formation. Although the primary treatment option is pars plana vitrectomy; cases with spontaneous closure in the literature have also been reported. In this study, we aimed to present a case who had persistent vitreomacular traction induced macular hole following intravitreal ranibizumab injection due to exudative age-related macular degeneration and underwent pars plana vitrectomy

Özet

İntravitreal enjeksiyon sonrası maküler delik oluşumu nadir komplikasyonlardan birisidir. Maküler delik oluşumundan sorumlu olabilecek çeşitli mekanizmalar olabilir. Primer tedavi seçeneği pars plana vitrektomi olmasına rağmen; literatürde spontan kapanma olan olgular da bildirilmiştir. Bu çalışmada eksüdatif yaşa bağlı maküla dejenerasyonu sebebiyle yapılan intravitreal ranibizumab enjeksiyonunu takiben persistan vitreomaküler traksiyona bağlı maküler hole gelişen ve pars plana vitrektomi yapılan olguyu sunmayı amaçladık.

🔖

Cite This Article

GÜMÜŞ, G., DEMİR, G., ALKIN, Z. (2019). Macular Hole Development Following Intravitreal Injection in a Patient with Exudative Age-Related Macular Degeneration. MN Oftalmoloji, Cilt: 26 - Sayı: 2, 110–113. https://ajindex.com/articles/295375

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. La Cour M, Friis J. Macular holes: classification, epidemiology, natural history and treatment. Acta Ophthalmol Scand. 2002; 80(6):579-87
  2. Gaudric A, Tadayoni R. Macular hole. In: Retina (Volume 3). Ryan SJ, Schachat AP (Eds). Elsevier Mosby, Philadelphia, USA. 2013;1883-9
  3. Gass JD. Idiopathic senile macular hole: Its early stages and pathogenesis. Arch Ophthalmol. 1998;106:629-39
  4. Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye. 2013;27(7):787-94 5. Chung EJ, Koh HJ. Retinal detachment with macular hole following combined photodynamic therapy and intravitreal bevacizumab injection. Korean J Ophthalmol. 2007;21:185-7
  5. Querques G, Souied EH, Soubrane G. Macular hole following intravitreal ranibizumab injection for choroidal neovascular membrane caused by age-related macular degeneration. Acta Ophthal - mol. 2009;87:235-7
  6. Kim SS, Smiddy WE, Feuer WJ, et al. Outcomes of sulfur hexafluoride (SF6) versus perfluoropropane (C3F8) gas tamponade for macular hole surgery. Retina. 2008;28(10):1408-15
  7. Briand S, Chalifoux E, Tourville E, et al. Prospective randomized trial: outcomes of SF6 versus C3F8 in macular hole surgery. Can J Ophthalmol. 2015;50(2):95-100
  8. Spandau UH, Jonas JB. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol. 2006;142:1068-70.